Johnson & Johnson (JNJ): Officer sold ~$2.41M

~$2.41M

Approx. value · 10K sh @ $241.15

114K

Holds after · shares reported

Traded

Jun 11, 2026

Filed

Jun 12, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Dec 16, 2025Federal contractDepartment of Veterans Affairs awarded Johnson & Johnson: $0 obligated to date
2. Feb 23, 2026Federal contract · $371K obligatedDepartment of Defense awarded Johnson & Johnson: $371K obligated to date
3. Feb 26, 2026Federal contract · $272K obligatedDepartment of Defense awarded Johnson & Johnson: $272K obligated to date
4. Mar 4, 2026Federal contract · $205K obligatedDepartment of Defense awarded Johnson & Johnson: $205K obligated to date
5. Mar 16, 2026Federal contract · $205K obligatedDepartment of Defense awarded Johnson & Johnson: $205K obligated to date
6. Mar 19, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
7. Mar 26, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
8. Mar 27, 2026CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
9. Mar 30, 2026CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
10. Apr 10, 2026Federal contract · $198K obligatedDepartment of Defense awarded Johnson & Johnson: $198K obligated to date
11. Apr 14, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
12. May 1, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
13. May 28, 2026Federal contract · $21K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $21K obligated to date
14. Jun 2, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
15. Jun 9, 2026CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
16. Jun 11, 2026 · this disclosureInsider · First sale since 2023Officer sold ~$2.41M of JNJ shares in the open market

What came next

1. Jun 25, 2026FDAFDA device clearance: Coated VICRYL™ (Polyglactin 910) Plus Antibacterial Suture
2. Jun 25, 2026FDAFDA device clearance: ATTUNE Total Knee System; ATTUNE Cementless Knee System
3. Jun 25, 2026FDAFDA device clearance: VELYS™ Robotic-Assisted Solution
4. Jun 29, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
5. Jul 7, 2026Federal contract · $168K obligatedDepartment of Defense awarded Johnson & Johnson: $168K obligated to date
6. Jul 15, 2026Company filing · Form 8-K · ResultsReported its results
7. Jul 20, 2026InsiderOfficer sold ~$5.79M of JNJ shares in the open market
8. Jul 23, 2026FDARecall: Velys Enabling Tech Robotic-Assist Station REF: 451611001
9. Jul 23, 2026Federal contract · $182K obligatedDepartment of Defense awarded Johnson & Johnson: $182K obligated to date
10. Jul 25, 2026FDAFDA device clearance: MONARCH™ Platform (MON-000008)
11. Jul 27, 2026FDAFDA device clearance: Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripheral IVL Catheter
12. Jul 30, 2026Federal contract · $385K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $385K obligated to date
13. Jul 30, 2026CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
14. Jul 31, 2026FDARecall: HEALON EndoCoat PRO, REF: 10300012 (US/CAN) HEALON DUET PRO II, REF: 10300016 (US/CAN) HEALON EndoCoat PRO, REF: 10301012 (EU); HEALON DUET PRO II, REF: 103010…
15. Jul 31, 2026Federal contract · $21K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $21K obligated to date
16. Aug 4, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 4, 2026, the Company announced that Jennifer Taubert will retire from her position as Executive Vice President, Worldwide Chairman, Innovative Medicine and member of the Executive Committee effective September 1, 2026.”
17. Aug 5, 2026Insider · 1 personInsiders: 2 sales (~$12.5M)
18. Aug 6, 2026Insider · 1 personInsiders: 2 sales (~$4.1M)
19. Aug 12, 2026FDARecall: Automated Impella Controller (AIC) with the below product descriptions and corresponding Product Codes. 1. Impella Controller, Packaged, CA; Product Code: 0042…
20. Aug 12, 2026FDARecall: Impella Optical Controller, Automated Impella Controller, Impella Connect Package with the below product descriptions and corresponding Product Codes. 1. Optic…

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 119 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Johnson & Johnson

• House Clerk periodic transaction reportOct 5, 2026
• USAspending.gov award recordOct 5, 2026
• USAspending.gov award recordSep 24, 2026
• USAspending.gov award recordSep 22, 2026
• USAspending.gov award recordSep 21, 2026
• House Clerk periodic transaction reportSep 12, 2026

Everything OQRO holds on this company is on its JNJ page.